About Xinvento
Xinvento is a company based in Amsterdam (Netherlands) founded in 2021 by Sarah Hafith and Piet Wigerinck was acquired by Rhythm Pharmaceuticals in February 2023.. Xinvento offers products and services including CHI Treatment.
- Headquarter Amsterdam, Netherlands
- Founders Sarah Hafith, Piet Wigerinck
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Xinvento Bv
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Rhythm Pharmaceuticals
& 8 more
-
Employee Count
Employee Count
-
Acquired by
Rhythm Pharmaceuticals
(Feb 27, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xinvento
Xinvento offers a comprehensive portfolio of products and services, including CHI Treatment. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Developing alternative treatments to manage congenital hyperinsulinism symptoms effectively.
Unlock access to complete
Unlock access to complete
Funding Insights of Xinvento
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Seed - Xinvento | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Xinvento
Xinvento has secured backing from 9 investors, including angel investors. Prominent investors backing the company include Rhythm Pharmaceuticals, Ed Kaye and John Maraganore. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
EK
Ed Kaye |
-
|
Founded Year | Domain | Location |
|
JM
John Maraganore |
-
|
Founded Year | Domain | Location |
|
DM
David Meeker |
Angel investor focusing on Indian startups, limited public data available.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Xinvento
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Xinvento
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Xinvento Comparisons
Competitors of Xinvento
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Xinvento
Frequently Asked Questions about Xinvento
When was Xinvento founded?
Xinvento was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Xinvento located?
Xinvento is headquartered in Amsterdam, Netherlands.
What does Xinvento do?
Xinvento was founded in 2021 and is based in Amsterdam, Netherlands. Focus is placed on the research and development of treatments for congenital hyperinsulinism, a rare disease marked by persistent hypoglycemia. Operations center on advancing therapies within the biotechnology sector to address this condition, with activities conducted primarily in Europe. Key personnel include co-founders Sarah Hafith and Piet Wigerinck.
What products or services does Xinvento offer?
Xinvento offers CHI Treatment.
Who are Xinvento's investors?
Xinvento has 9 investors. Key investors include Rhythm Pharmaceuticals, Ed Kaye, John Maraganore, David Meeker, and James Shannon.